Stretch-induced expression of vascular endothelial growth factor (VEGF) is thought to be important in mediating the exacerbation of diabetic retinopathy by systemic hypertension. However, the mechanisms underlying stretch-induced VEGF expression are not fully understood. We present novel findings demonstrating that stretch-induced VEGF expression in retinal capillary pericytes is mediated by phosphatidylinositol (PI) 3-kinase and protein kinase C (PKC)-but is not mediated by ERK1/2, classical/novel isoforms of PKC, Akt, or Ras despite their activation by stretch. Cardiac profile cyclic stretch at 60 cpm increased VEGF mRNA expression in a time-and magnitude-dependent manner without altering mRNA stability. Stretch increased ERK1/2 phosphorylation, PI 3-kinase activity, Akt phosphorylation, and PKCactivity. Signaling pathways were explored using inhibitors of PKC, MEK1/2, and PI 3-kinase; adenovirus-mediated overexpression of ERK, PKC-␣, PKC-␦, PKC-, and Akt; and dominant negative (DN) mutants of ERK, PKC-, Ras, PI 3-kinase and Akt. Although stretch activated ERK1/2 through a Ras-and PKC classical/novel isoformdependent pathway, these pathways were not responsible for stretch-induced VEGF expression. Overexpression of DN ERK and Ras had no effect on VEGF expression in these cells. In contrast, DN PI 3-kinase as well as pharmacologic inhibitors of PI 3-kinase blocked stretch-induced VEGF expression. Although stretch-induced PI 3-kinase activation increased both Akt phosphorylation and activity of PKC-, VEGF expression was dependent on PKCbut not Akt. In addition, PKC-did not mediate stretchinduced ERK1/2 activation. These results suggest that stretch-induced expression of VEGF involves a novel mechanism dependent upon PI 3-kinase-mediated activation of PKC-that is independent of stretch-induced activation of ERK1/2, classical/novel PKC isoforms, Ras, or Akt. This mechanism may play a role in the well documented association of concomitant hypertension with clinical exacerbation of neovascularization and vascular permeability.One in four American adults has hypertension, while 5.9% of the United States population (over 15 million people) have diabetes. Diabetic retinopathy is the leading cause of new onset blindness in the United States among working age individuals (1) and is exacerbated by coexistent systemic hypertension (2-4). Sight-threatening diabetic retinopathy is characterized by development of retinal neovascularization and/or retinal vascular permeability (5). Hypertension increases the risk of retinopathy progression, development of neovascularization (2, 6, 7), and retinal vascular permeability (8, 9) by up to 3-fold. Blood pressure control reduces both retinopathy progression and severe visual loss (10). Even in normotensive diabetic patients retinopathy is associated with higher systolic blood pressure (11). Other vision-threatening conditions such as hypertensive retinopathy (12) and age-related macular degeneration are also aggravated by hypertension (13).Although the mechanisms underlying the exace...